Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Factors affecting interactions between prion protein isoforms.

Caughey B, Baron GS.

Biochem Soc Trans. 2002 Aug;30(4):565-9.

PMID:
12196138
2.

Formation of protease-resistant prion protein in cell-free systems.

Caughey B.

Curr Issues Mol Biol. 2000 Jul;2(3):95-101. Review.

3.

Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain.

Horiuchi M, Baron GS, Xiong LW, Caughey B.

J Biol Chem. 2001 May 4;276(18):15489-97. Epub 2001 Feb 1.

5.

Prion protein and species barriers in the transmissible spongiform encephalopathies.

Priola SA.

Biomed Pharmacother. 1999;53(1):27-33. Review.

PMID:
10221165
7.

Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Wong C, Xiong LW, Horiuchi M, Raymond L, Wehrly K, Chesebro B, Caughey B.

EMBO J. 2001 Feb 1;20(3):377-86.

8.

N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.

Lawson VA, Priola SA, Wehrly K, Chesebro B.

J Biol Chem. 2001 Sep 21;276(38):35265-71. Epub 2001 Jul 20.

9.
10.
12.

Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.

Vorberg I, Raines A, Priola SA.

J Biol Chem. 2004 Jul 9;279(28):29218-25. Epub 2004 May 7.

13.

Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform.

Vorberg I, Groschup MH, Pfaff E, Priola SA.

J Virol. 2003 Feb;77(3):2003-9.

14.

Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.

Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Bossers A, Ironside J, Will RG, Chen SG, Petersen RB, Gambetti P, Rubenstein R, Smits MA, Lansbury PT Jr, Caughey B.

Nature. 1997 Jul 17;388(6639):285-8.

PMID:
9230438
15.
16.
17.

[Biology of non-conventional transmissible agents or prions].

Dormont D.

Rev Neurol (Paris). 1998 Feb;154(2):142-51. Review. French.

PMID:
9773035
18.

Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.

Xiong LW, Raymond LD, Hayes SF, Raymond GJ, Caughey B.

J Neurochem. 2001 Nov;79(3):669-78.

19.
20.

Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.

Cordes H, Bergström AL, Ohm J, Laursen H, Heegaard PM.

J Immunol Methods. 2008 Sep 15;337(2):106-20. doi: 10.1016/j.jim.2008.07.004. Epub 2008 Jul 25.

PMID:
18657541

Supplemental Content

Support Center